Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Ketanest

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 388Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pharmather Updates On Ketamine Development And Commercial
    Pharmather Updates On Ketamine Development And Commercial

    02 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/02/3160310/0/en/PharmaTher-Provides-Corporate-Update-on-Ketamine-Development-and-Commercial-Strategy.html

    GLOBENEWSWIRE
    02 Oct 2025
    Share Share
    Pharmather Sells Ketamine ANDA, Poised For $25M+ In Payments
    Pharmather Sells Ketamine ANDA, Poised For $25M+ In Payments

    01 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/01/3159435/0/en/PharmaTher-Announces-Sale-of-Ketamine-ANDA-with-Potential-to-Generate-Over-US-25-Million-in-Milestone-and-Profit-Sharing-Payments.html

    GLOBENEWSWIRE
    01 Oct 2025
    Share Share
    Nrx Pharma Resubmits ANDA For Ketafree
    Nrx Pharma Resubmits ANDA For Ketafree

    29 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/29/3157687/0/en/NRx-Pharmaceuticals-Inc-NASDAQ-NRXP-Re-Files-Abbreviated-New-Drug-Application-ANDA-for-KETAFREE-Preservative-Free-IV-Ketamine.html

    GLOBENEWSWIRE
    29 Sep 2025
    Share Share
    Harrow To Acquire Melt Pharmaceuticals
    Harrow To Acquire Melt Pharmaceuticals

    26 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/26/3156941/0/en/Harrow-to-Acquire-Melt-Pharmaceuticals.html

    GLOBENEWSWIRE
    26 Sep 2025
    Share Share
    NRx Pharmaceuticals Implements Expanded Access for NRX-100
    NRx Pharmaceuticals Implements Expanded Access for NRX-100

    27 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/27/3139980/0/en/NRx-Pharmaceuticals-Inc-NASDAQ-NRXP-Announces-Expanded-Access-Policy-for-NRX-100-preservative-free-ketamine.html

    GLOBENEWSWIRE
    27 Aug 2025
    Share Share
    PharmaTher Updates Post FDA Approval for Ketamine (KETARx™)
    PharmaTher Updates Post FDA Approval for Ketamine (KETARx™)

    26 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/26/3139203/0/en/PharmaTher-Provides-Corporate-Update-Following-FDA-Approval-of-Ketamine-KETARx.html

    GLOBENEWSWIRE
    26 Aug 2025
    Share Share